A U of M startup has garnered seed investments to develop its faster, more accurate disease detection technology.
A recent Association of University Technology Managers survey ranked the U of M second among Big Ten schools when it comes to licensing revenue.
University of Minnesota scientists contributed to the preclinical work that led to the first-ever clinical trial of a gene therapy that edit the DNA from inside the body.
Innovation fellows from the U of M's Medical Devices Center have developed an app that may cure snoring.
Warren Watson, a medical device industry consultant and former vice president of Medtronic, highlights how U research is helping shape Minnesota's business environment.
U of M startup CoreBiome has partnered with a clinical-stage biotech company to harness the health potential of gut microbes.
The U of M's Jay Schrankler, associate vice president of technology commercialization and new ventures, discusses the rise in industry-funded research and technology commercialization.
U researchers have earned a patent for a new kind of injectable antidote for cyanide poisoning.
University apple breeder David Bedford recently discussed Minnesota's signature apple varieties and the U's newest release.
U of M-developed cold-hardy wine grapes are part of a growing industry.
Sign up for the UMN Research newsletter >